NCT06688422Recruiting
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Incentive Spirometry for Respiratory Enhancement Pilot Clinical Trial in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if using an incentive spirometer can reduce lung problems in people with advanced lung cancer who are receiving chemotherapy and radiation therapy. The main questions the study aims to answer are: Does using an incentive spirometer lower the chances of developing lung inflammation (pneumonitis)? Does it improve overall survival and quality of life? Participants will: Use an incentive spirometer, a device that helps with deep breathing, 10 times every hour while awake. Continue using the spirometer daily during treatment and for up to three months after treatment. Complete quality of life assessments at the start of the study and at 3, 6, and 12 months. Researchers will compare the results to see if the incentive spirometer helps reduce lung problems and improves participants\' well-being during and after their cancer treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 9 Nov 2024
- Start date
- 1 Dec 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- The Cooper Health System
- Diseases
- Lung cancer
- NCT number
- NCT06688422
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Dec 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous lung or thoracic surgery
- Home oxygen usage prior to enrolment
- Prior exposure to drugs such as amiodarone, bleomycin, or immunotherapy
Other illness
- Radiological evidence of pleural effusion, pneumothorax, bullous emphysema, - or pneumonitis on staging imaging
- Presence of active respiratory tract infection
Other
- Enrollment in another pulmonary intervention trial
- Uncontrolled nausea and vomiting
- Inability or unwillingness of individual to give written informed consent
Who the study is looking for
- Confirmed diagnosis of advanced non-small-cell lung cancer
- Performance status (ECOG 0-1)
- Eligible for concurrent chemotherapy and radiation
- 18 years or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center at Cooper Coordinator of this site? Confirm its status | Camden | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.